183 related articles for article (PubMed ID: 35121343)
21. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.
Hörl G; Kroisel PM; Wagner E; Tiran B; Petek E; Steyrer E
Atherosclerosis; 2006 Jul; 187(1):101-9. PubMed ID: 16216249
[TBL] [Abstract][Full Text] [Related]
22. Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.
Tobar HE; Cataldo LR; González T; Rodríguez R; Serrano V; Arteaga A; Álvarez-Mercado A; Lagos CF; Vicuña L; Miranda JP; Pereira A; Bravo C; Aguilera CM; Eyheramendy S; Uauy R; Martínez Á; Gil Á; Francone O; Rigotti A; Santos JL
Lipids Health Dis; 2019 Jun; 18(1):132. PubMed ID: 31164121
[TBL] [Abstract][Full Text] [Related]
23. Lecithin:cholesterol acyltransferase-induced transformation of HepG2 lipoproteins.
McCall MR; Nichols AV; Blanche PJ; Shore VG; Forte TM
J Lipid Res; 1989 Oct; 30(10):1579-89. PubMed ID: 2515238
[TBL] [Abstract][Full Text] [Related]
24. Role of N-linked glycosylation of lecithin:cholesterol acyltransferase in lipoprotein substrate specificity.
O K; Hill JS; Pritchard PH
Biochim Biophys Acta; 1995 Jan; 1254(2):193-7. PubMed ID: 7827124
[TBL] [Abstract][Full Text] [Related]
25. Recombinant LCAT (Lecithin:Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary Syndrome.
Ossoli A; Simonelli S; Varrenti M; Morici N; Oliva F; Stucchi M; Gomaraschi M; Strazzella A; Arnaboldi L; Thomas MJ; Sorci-Thomas MG; Corsini A; Veglia F; Franceschini G; Karathanasis SK; Calabresi L
Arterioscler Thromb Vasc Biol; 2019 May; 39(5):915-924. PubMed ID: 30894011
[TBL] [Abstract][Full Text] [Related]
26. Lipoprotein X Causes Renal Disease in LCAT Deficiency.
Ossoli A; Neufeld EB; Thacker SG; Vaisman B; Pryor M; Freeman LA; Brantner CA; Baranova I; Francone NO; Demosky SJ; Vitali C; Locatelli M; Abbate M; Zoja C; Franceschini G; Calabresi L; Remaley AT
PLoS One; 2016; 11(2):e0150083. PubMed ID: 26919698
[TBL] [Abstract][Full Text] [Related]
27. Very low levels of HDL cholesterol and atherosclerosis, a variable relationship--a review of LCAT deficiency.
Savel J; Lafitte M; Pucheu Y; Pradeau V; Tabarin A; Couffinhal T
Vasc Health Risk Manag; 2012; 8():357-61. PubMed ID: 22701329
[TBL] [Abstract][Full Text] [Related]
28. Fish eye syndrome: a molecular defect in the lecithin-cholesterol acyltransferase (LCAT) gene associated with normal alpha-LCAT-specific activity. Implications for classification and prognosis.
Klein HG; Santamarina-Fojo S; Duverger N; Clerc M; Dumon MF; Albers JJ; Marcovina S; Brewer HB
J Clin Invest; 1993 Jul; 92(1):479-85. PubMed ID: 8326012
[TBL] [Abstract][Full Text] [Related]
29. Novel therapeutic opportunities for familial lecithin:cholesterol acyltransferase deficiency: promises and challenges.
Vitali C; Rader DJ; Cuchel M
Curr Opin Lipidol; 2023 Apr; 34(2):35-43. PubMed ID: 36473023
[TBL] [Abstract][Full Text] [Related]
30. Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport.
Dobiásová M; Frohlich JJ
Clin Chim Acta; 1999 Aug; 286(1-2):257-71. PubMed ID: 10511297
[TBL] [Abstract][Full Text] [Related]
31. Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice.
Xepapadaki E; Maulucci G; Constantinou C; Karavia EA; Zvintzou E; Daniel B; Sasson S; Kypreos KE
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1351-1360. PubMed ID: 30742993
[TBL] [Abstract][Full Text] [Related]
32. High density lipoproteins and coronary heart disease. Future prospects in gene therapy.
Fruchart JC; Duriez P
Biochimie; 1998 Feb; 80(2):167-72. PubMed ID: 9587674
[TBL] [Abstract][Full Text] [Related]
33. CER-001 ameliorates lipid profile and kidney disease in a mouse model of familial LCAT deficiency.
Ossoli A; Strazzella A; Rottoli D; Zanchi C; Locatelli M; Zoja C; Simonelli S; Veglia F; Barbaras R; Tupin C; Dasseux JL; Calabresi L
Metabolism; 2021 Mar; 116():154464. PubMed ID: 33309714
[TBL] [Abstract][Full Text] [Related]
34. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
[TBL] [Abstract][Full Text] [Related]
35. Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.
Ng DS; Francone OL; Forte TM; Zhang J; Haghpassand M; Rubin EM
J Biol Chem; 1997 Jun; 272(25):15777-81. PubMed ID: 9188474
[TBL] [Abstract][Full Text] [Related]
36. Effect of the cholesterol content of reconstituted LpA-I on lecithin:cholesterol acyltransferase activity.
Sparks DL; Anantharamaiah GM; Segrest JP; Phillips MC
J Biol Chem; 1995 Mar; 270(10):5151-7. PubMed ID: 7890624
[TBL] [Abstract][Full Text] [Related]
37. Adenoviral expression of human lecithin-cholesterol acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein and lowering low-density lipoprotein.
Amar MJ; Shamburek RD; Vaisman B; Knapper CL; Foger B; Hoyt RF; Santamarina-Fojo S; Brewer HB; Remaley AT
Metabolism; 2009 Apr; 58(4):568-75. PubMed ID: 19303980
[TBL] [Abstract][Full Text] [Related]
38. A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency.
Vitali C; Bajaj A; Nguyen C; Schnall J; Chen J; Stylianou K; Rader DJ; Cuchel M
J Lipid Res; 2022 Mar; 63(3):100169. PubMed ID: 35065092
[TBL] [Abstract][Full Text] [Related]
39. LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea.
Flores R; Jin X; Chang J; Zhang C; Cogan DG; Schaefer EJ; Kruth HS
Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31779197
[TBL] [Abstract][Full Text] [Related]
40. Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.
Calabresi L; Simonelli S; Conca P; Busnach G; Cabibbe M; Gesualdo L; Gigante M; Penco S; Veglia F; Franceschini G
J Intern Med; 2015 May; 277(5):552-61. PubMed ID: 25039266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
